Contravisory Investment Management, Inc. Bristol Myers Squibb CO Transaction History

Contravisory Investment Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	BUY	$68.48 - $81.09 $320,280 - $379,257	4,677 New	4,677 $0
Q3 2020 Oct 08, 2020	SELL	$57.43 - $63.64 $206,805 - $229,167	-3,601 Closed	0 $0
Q2 2020 Jul 09, 2020	BUY	$54.82 - $64.09 $197,406 - $230,788	3,601 New	3,601 $205,000
Q1 2018 Apr 09, 2018	SELL	$59.92 - $68.98 $9,527 - $10,967	-159 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$59.94 - $65.35 $3,536 - $3,855	59 Added 59.0%	159 $10,000
Q3 2017 Oct 12, 2017	BUY	$55.23 - $63.74 $5,523 - $6,374	100	100 $6,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.